Siemens Healthineers stock: Citi raises target for Siemens Healthineers stock to EUR 47.00
Published on 10/16/2026 at 17:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and calendar
- On October 13, Citi raised its Siemens Healthineers target from EUR 46.00 to EUR 47.00.
- Siemens Healthineers will publish fourth-quarter results on November 5, 2026.
- Siemens Healthineers stock stood at EUR 41.49 on October 16, 2026 at 5:16 p.m. CEST, up 1.57 percent versus the Xetra close of October 15, 2026.
- Market capitalization was EUR 46.4 billion and the price-to-earnings ratio was 20.95 on October 16, 2026.
Citi raised its price target for Siemens Healthineers from EUR 46.00 to EUR 47.00 on October 13, 2026, while retaining a Buy rating, according to Markets Insider. The new target was 13.28 percent above the latest Xetra quote of EUR 41.49. The stock stood at EUR 41.49 on October 16, 2026 at 5:16 p.m. CEST, up 1.57 percent versus the Xetra close of October 15, 2026.
November 5 results date
Siemens Healthineers will publish its fourth-quarter results and hold an analyst call on November 5, 2026. The date appears in the company investor-relations calendar, which also identifies the July 31, 2026 report as the latest quarterly update, according to Siemens Healthineers. That event gives investors a defined checkpoint for margins, orders and the delivery of the group's medical-technology strategy.
Stock sits below yearly high
The Xetra quote was 16.54 percent below the 52-week high of EUR 49.71 and 26.45 percent above the 52-week low of EUR 32.81 on October 16, 2026. Trading volume was 508,841 shares against an average of 912,229 shares, placing the session below its recent average activity. The company develops imaging, diagnostics, cancer-care and advanced-therapy equipment for healthcare providers.
Valuation and next date
Siemens Healthineers had a market capitalization of EUR 46.4 billion and a price-to-earnings ratio of 20.95 on October 16, 2026. The November 5 report is the next scheduled corporate date and will provide the next periodized operating figures. The recent analyst picture is split between Citi's EUR 47.00 target and the wider target range cited in current market coverage, making the results a test of whether earnings execution can support the higher view.
Comparison with peers
Siemens Healthineers: plus 1.57 percent, P/E 20.95, market capitalization EUR 46.4 billion
Koninklijke Philips (Euronext Amsterdam, EUR): plus 1.89 percent, P/E 19.92, market capitalization EUR 22.6 billion
GE HealthCare (NYSE, USD): P/E 20.39, market capitalization USD 31.8 billion
Price and trading position
The stock's EUR 41.49 Xetra quote on October 16, 2026 at 5:16 p.m. CEST was above the EUR 40.85 Xetra close of October 15, 2026. Its position remains materially below the EUR 49.71 yearly high, while the next scheduled results date gives the market a concrete test for the valuation.
Market context: Market report DAX.
